Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-06-24
1995-05-16
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514280, 546 62, 546 70, 546 58, 546 54, 546 47, 549384, 549382, A61K 3147
Patent
active
054160898
ABSTRACT:
Anticancer compounds of formula I: ##STR1## and pharmaceutically acceptable salts thereof, wherein: R.sup.1, R.sup.2 and R.sup.3 are independently selected H, CH.sub.3, NH.sub.2, NO.sub.2, and CN;
REFERENCES:
patent: 4841052 (1989-06-01), Harnisch et al.
patent: 4874863 (1989-10-01), Brana et al.
patent: 5086059 (1992-02-01), Ardecky et al.
patent: 5206249 (1993-04-01), Sun
patent: 5206250 (1993-04-01), Sun
patent: 5290931 (1994-03-01), Himeno et al.
El-Nagger et al., Chem. Abstracts 1982, 99, 88558r.
Horiguchi et al., Chem. Abstracts 1972, 76, 87174a.
Horiguchi et al. Chem. Abstracts 1972, 76, 871756.
Akamike Emeka A.
Cherney Robert J.
Kaltenbach III Robert F.
Orwat Michael J.
Pacofsky Gregory
Boudreaux Gerald J.
Daus Donald G.
The Du Pont Merck Pharmaceutical Company
LandOfFree
Polycyclic and heterocyclic chromophores for bis-imide tumoricid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polycyclic and heterocyclic chromophores for bis-imide tumoricid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polycyclic and heterocyclic chromophores for bis-imide tumoricid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-637860